Delivery Order 75F40121D00009-75F40122F19002
Award Date 5/26/22
Potential Completion Date 9/26/22
Potential Value $149K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $147,859.57 firm fixed-price delivery order issued under the Qiagen IDIQ contract (75F40121D00009) by the Food and Drug Administration (FDA), a civilian federal agency. The order is for the purchase of molecular biology reagents, with no set-aside designation. The prime contractor is Qiagen, LLC, a foreign-owned, for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. Qiagen, LLC is...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $34,270.50 firm fixed price delivery order contract to Qiagen, LLC for the purchase of molecular biology reagents. Qiagen, LLC will deliver the requested reagents under contract number CDER-2023-118902 from September 9, 2023 through September 10, 2024. As the prime contractor, Qiagen will perform the work itself at its facility in Germantown, Maryland. The award draws from HHS FDA's budget to support its...
- This is a federal contract award to Qiagen, LLC, a division of the biotechnology company Qiagen N.V. The contract, awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), has a ceiling value of $107,401.82 and is a firm fixed-price purchase order with an ultimate completion date of August 22, 2019. The contract provides for the addition of funding to an original requisition, without any set-aside designation. Qiagen, a...
- This is a delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $27,299.50 firm fixed price contract does not have a set-aside designation. Qiagen has provided a range of goods and services to support federal biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing,...
- Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V., received a delivery order award from the Food and Drug Administration (FDA) on July 24, 2018, for Array Kits valued at $18,126.83 with a firm fixed price contract type. The delivery order was issued without a set-aside designation and is scheduled for ultimate completion on September 30, 2018. Performance will be executed at Qiagen's facility in Valencia, California. This award represents a task order under the FDA's existing indefinite...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a subsidiary of Qiagen N.V., for the procurement of QIAGEN RNeasy Power Microbiome Kits. The contract has a ceiling value of $80,317.60 and a period of performance ending on September 30, 2018. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia, and has a history of providing a range of goods and services to...
- This is a delivery order against a broader Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The contract is for the purchase of $33,904.98 in molecular biology reagents. This order falls under the QIAGEN IDIQ, a multi-year, agency-wide IDC that enables the FDA to place recurring orders for specialized scientific consumables and equipment as needed. The...
- This is a $404,000.00 firm fixed-price delivery order contract awarded by the Headquarters Division of a civilian federal agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is for the supply of QIAGEN reagents and consumables, with a period of performance through April 2, 2026. The contract does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...